A2A antagonist in combination with an anticholinergic agent for the treatment of obstructive Airway Diseases

摘要

The present Invention relates to a combination of a selective A2A adenosine receptor agonist AND anticholinergic agent for managing simultaneous, consecutive or separate via inhalation in the treatment of a disease or other obstructive Airway disease Inflammatory, under the condition that the anticholinergic Agent is not a tiotropium Salt.